Tadashi Murase
About
In The Last Decade
Tadashi Murase
23 papers receiving 702 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 254
- Oncology 178
- Radiology, Nuclear Medicine and Imaging 152
- Pulmonary and Respiratory Medicine 122
- Hematology 102
Countries citing papers authored by Tadashi Murase
This map shows the geographic impact of Tadashi Murase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Murase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Murase more than expected).
Fields of papers citing papers by Tadashi Murase
This network shows the impact of papers produced by Tadashi Murase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Murase. The network helps show where Tadashi Murase may publish in the future.
Co-authorship network of co-authors of Tadashi Murase
This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Murase. A scholar is included among the top collaborators of Tadashi Murase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Murase. Tadashi Murase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Spatio-temporal probabilistic methodology and computational platform for common cause failure modeling in risk analysis | 5 |
| 3 | 52 | |
| 4 | 28 | |
| 5 | 5 | |
| 6 | 9 | |
| 7 | 5 | |
| 8 | 0 | |
| 9 | 15 | |
| 10 | 14 | |
| 11 | 4 | |
| 12 | 25 | |
| 13 | 4 | |
| 14 | 2 | |
| 15 | 59 | |
| 16 | 1 | |
| 17 | Acute myeloid leukemia in the elderly:--159 Nagoya case studies--Nagoya Cooperative Study Group for Elderly Leukemia. | 3 |
| 18 | 174 | |
| 19 | 124 | |
| 20 | Bilineage hematopoietic inhibitor and T lymphocyte dysfunction in a patient with pure red cell aplasia, myasthenia gravis and thymoma. | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.